Lithium use in bipolar disorder: Summary of evidence for acute mania, acute depression, and maintenance treatment

Mental Health Clinician

Volumn 2, Issue 1, 2012, Pages 10-14

  DeJongh, Beth ^a  

^a Department of Pharmaceutical Sciences   (United States)

Author keywords

acute depression; acute mania; bipolar disorder; lithium; maintenance

Indexed keywords

EID: 85062375560     PISSN: None     EISSN: 21689709     Source Type: Journal    
DOI: 10.9740/mhc.n110748     Document Type: Article

References (32)

1. Fountoulakis KN, Vieta E, Sanchez-Moreno J, Kaprinis SG, Goikolea JM, Kaprinis GS. Treatment guidelines for bipolar disorder: a critical review. J Affect Disord. 2005;86(1):1-10. DOI: 10.1016/j.jad.2005.01.004. PubMed PMID: 15820265.
2. Practice guideline for the treatment of patients with bipolar disorder (revision). Am J Psychiatry. 2002;159(4 Suppl):1-50. PubMed PMID: 11958165.
3. Yatham LN, Kennedy SH, Schaffer A, Parikh SV, Beaulieu S, O'Donovan C, et al. Canadian Network for Mood and Anxiety Treatments (CANMAT) and International Society for Bipolar Disorders (ISBD) collaborative update of CANMAT guidelines for the management of patients with bipolar disorder: update 2009. Bipolar Disord. 2009;11(3):225-55. DOI: 10.1111/j.1399-5618.2009.00672.x. PubMed PMID: 19419382.
4. Suppes T, Dennehy EB, Swann AC, Bowden CL, Calabrese JR, Hirschfeld RMA, et al. Report of the Texas Consensus Conference Panel on medication treatment of bipolar disorder 2000. J Clin Psychiatry. 2002;63(4):288-99. PubMed PMID: 12004801.
5. Goodwin GM. Evidence-based guidelines for treating bipolar disorder: revised second edition-recommendations from the British Association for Psychopharmacology. J Psychopharmacol. 2009;23(4):346-88. DOI: 10.1177/0269881109102919. PubMed PMID: 19329543.
6. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Moller H-J, et al. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders: update 2009 on the treatment of acute mania. World J Biol Psychiatry. 2009;10(2):85-116. DOI: 10.1080/15622970902823202. PubMed PMID: 19347775.
7. Swann AC, Bowden CL, Morris D, Calabrese JR, Petty F, Small J, et al. Depression during mania. Treatment response to lithium or divalproex. Arch Gen Psychiatry. 1997;54(1):37-42. PubMed PMID: 9006398.
8. Bowden CL, Brugger AM, Swann AC, Calabrese JR, Janicak PG, Petty F, et al. Efficacy of divalproex vs lithium and placebo in the treatment of mania. The Depakote Mania Study Group. JAMA. 1994;271(12):918-24. PubMed PMID: 8120960.
9. Bowden CL. Key treatment studies of lithium in manic-depressive illness: efficacy and side effects. J Clin Psychiatry 1998;59 Suppl 6:13-9; discussion 20.
10. Bowden CL, Grunze H, Mullen J, Brecher M, Paulsson B, Jones M, et al. A randomized, double-blind, placebo-controlled efficacy and safety study of quetiapine or lithium as monotherapy for mania in bipolar disorder. J Clin Psychiatry. 2005;66(1):111-21. PubMed PMID: 15669897.
11. Vieta E, Sanchez-Moreno J. Acute and long-term treatment of mania. Dialogues Clin Neurosci. 2008;10(2):165-79. PubMed PMID: 18689287.
12. Shopsin B, Gershon S, Thompson H, Collins P. Psychoactive drugs in mania. A controlled comparison of lithium carbonate, chlorpromazine, and haloperidol. Arch Gen Psychiatry. 1975;32(1):34-42. PubMed PMID: 1089401.
13. Vieta E. Atypical antipsychotics in the treatment of mood disorders. Curr Opin Psychiatry. 2003;16(1):23- 27. DOI: 10.1097/00001504-200301000-00006.
14. Garfinkel PE, Stancer HC, Persad E. A comparison of haloperidol, lithium carbonate and their combination in the treatment of mania. J Affect Disord. 1980;2(4):279-88. PubMed PMID: 6450787.
15. Johnstone EC, Crow TJ, Frith CD, Owens DG. The Northwick Park "functional" psychosis study: diagnosis and treatment response. Lancet. 1988;2(8603):119-25. PubMed PMID: 2899186.
16. Kemp DE, Muzina DJ, McIntyre RS, Calabrese JR. Bipolar depression: trial-based insights to guide patient care. Dialogues Clin Neurosci. 2008;10(2):181-92. PubMed PMID: 18689288.
17. Tondo L, Isacsson G, Baldessarini R. Suicidal behaviour in bipolar disorder: risk and prevention. CNS Drugs. 2003;17(7):491-511. PubMed PMID: 12751919.
18. Cipriani A, Pretty H, Hawton K, Geddes JR. Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: a systematic review of randomized trials. Am J Psychiatry. 2005;162(10):1805-19. DOI: 10.1176/appi.ajp.162.10.1805. PubMed PMID: 16199826.
19. Grunze H, Vieta E, Goodwin GM, Bowden C, Licht RW, Möller H-J, et al.. The World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for the Biological Treatment of Bipolar Disorders: Update 2010 on the treatment of acute bipolar depression. World J Biol Psychiatry. 2010;11(2):81-109. DOI: 10.3109/15622970903555881. PubMed PMID: 20148751.
20. Zornberg GL, Pope HG. Treatment of depression in bipolar disorder: new directions for research. J Clin Psychopharmacol. 1993;13(6):397-408. PubMed PMID: 8120153.
21. Young AH, McElroy SL, Bauer M, Philips N, Chang W, Olausson B, et al. A double-blind, placebo-controlled study of quetiapine and lithium monotherapy in adults in the acute phase of bipolar depression (EMBOLDEN I). J Clin Psychiatry. 2010;71(2):150-62. DOI: 10.4088/JCP.08m04995gre. PubMed PMID: 20122369.
22. Nemeroff CB, Evans DL, Gyulai L, Sachs GS, Bowden CL, Gergel IP, et al. Double-blind, placebo-controlled comparison of imipramine and paroxetine in the treatment of bipolar depression. Am J Psychiatry. 2001;158(6):906-12. PubMed PMID: 11384898.
23. Goodwin FK, Fireman B, Simon GE, Hunkeler EM, Lee J, Revicki D. Suicide risk in bipolar disorder during treatment with lithium and divalproex. JAMA. 2003;290(11):1467-73. DOI: 10.1001/jama.290.11.1467. PubMed PMID: 13129986.
24. Baldessarini RJ, Tondo L, Davis P, Pompili M, Goodwin FK, Hennen J. Decreased risk of suicides and attempts during long-term lithium treatment: a meta-analytic review. Bipolar Disord. 2006;8(5 Pt 2):625-39. DOI: 10.1111/j.1399-5618.2006.00344.x. PubMed PMID: 17042835.
25. Gonzalez-Pinto A, Mosquera F, Alonso M, López P, Ramírez F, Vieta E, et al.. Suicidal risk in bipolar I disorder patients and adherence to long-term lithium treatment. Bipolar Disord. 2006;8(5 Pt 2):618-24. DOI: 10.1111/j.1399-5618.2006.00368.x. PubMed PMID: 17042834.
26. Grunze H, Kasper S, Goodwin G, Bowden C, Möller H-J. The World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for the biological treatment of bipolar disorders, part III: maintenance treatment. World J Biol Psychiatry. 2004;5(3):120-35. PubMed PMID: 15346536.
27. Burgess S, Geddes J, Hawton K, Townsend E, Jamison K, Goodwin G. Lithium for maintenance treatment of mood disorders. Cochrane Database Syst Rev. 2001;(3):CD003013. DOI: 10.1002/14651858.CD003013. PubMed PMID: 11687035.
28. Davis JM, Janicak PG, Hogan DM. Mood stabilizers in the prevention of recurrent affective disorders: a meta-analysis. Acta Psychiatr Scand. 1999;100(6):406-17. PubMed PMID: 10626918.
29. Geddes JR, Burgess S, Hawton K, Jamison K, Goodwin GM. Long-term lithium therapy for bipolar disorder: systematic review and meta-analysis of randomized controlled trials. Am J Psychiatry. 2004;161(2):217-22. PubMed PMID: 14754766.
30. Muzina DJ, Calabrese JR. Maintenance therapies in bipolar disorder: focus on randomized controlled trials. Aust N Z J Psychiatry. 2005;39(8):652-61. DOI: 10.1111/j.1440-1614.2005.01649.x. PubMed PMID: 16050919.
31. Calabrese JR, Bowden CL, Sachs G, Yatham LN, Behnke K, Mehtonen OP, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently depressed patients with bipolar I disorder. J Clin Psychiatry. 2003;64(9):1013-24. PubMed PMID: 14628976.
32. Bowden CL, Calabrese JR, Sachs G, Yatham LN, Asghar SA, Hompland M, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003;60(4):392-400. DOI: 10.1001/archpsyc.60.4.392. PubMed PMID: 12695317.